860547P

C18 Glucosyl(β) Ceramide (d18:1/18:0)

Avanti Research^™ - A Croda Brand

• Synonym(e): D-glucosyl-β-1,1′-N-stearoyl-D-erythro-sphingosine
• Empirische Formel (Hill-System): C₄₂H₈₁NO₈
• CAS-Nummer: 95119-86-1
• Molekulargewicht: 728.09
• UNSPSC-Code: 12352211
• NACRES: NA.25

Eigenschaften

• Form: powder
• Verpackung: pkg of 1 × 100 mg (860547P-100mg); pkg of 1 × 25 mg (860547P-25mg); pkg of 1 × 5 mg (860547P-5mg)
• Hersteller/Markenname: Avanti Research^™ - A Croda Brand
• Lipid-Typ: sphingolipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [H][C@](/C=C/CCCCCCCCCCCCC)(O)[C@@]([H])(NC(CCCCCCCCCCCCCCCCC)=O)CO[C@H](O1)[C@H](O)[C@@H](O)[C@@H]([C@H]1CO)O
• InChI: 1S/C42H81NO8/c1-3-5-7-9-11-13-15-17-18-20-22-24-26-28-30-32-38(46)43-35(34-50-42-41(49)40(48)39(47)37(33-44)51-42)36(45)31-29-27-25-23-21-19-16-14-12-10-8-6-4-2/h29,31,35-37,39-42,44-45,47-49H,3-28,30,32-34H2,1-2H3,(H,43,46)/b31-29+/t35-,36+,37?,39+,40?,41?,42+/m0/s1
• InChIKey: YMYQEDCYNANIPI-KNSMPFANSA-N

Beschreibung

Anwendung

C18 Glucosyl(β) Ceramide (d18:1/18:0) or D-glucosyl-β-1,1′-N-stearoyl-D-erythro-sphingosine has been used:

• as a lipid standard for its quantification using differential ion mobility spectrometry (DMS) coupled with liquid chromatography in electrospray ionization tandem mass spectrometry (LC-ESI-DMS-MS/MS) in human plasma
• in the preparation of lipid dispersions
• used in an assay to monitor the turnover of glucosylceramide in glucocerebrosidase (GBA1) cell free system

Verpackung

5 mL Amber Glass Screw Cap Vial (860547P-100mg)

5 mL Amber Glass Screw Cap Vial (860547P-25mg)

5 mL Amber Glass Screw Cap Vial (860547P-5mg)

Rechtliche Hinweise

Avanti Research is a trademark of Avanti Polar Lipids, LLC

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids